Does AXITINIB Cause Squamous cell carcinoma? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Squamous cell carcinoma have been filed in association with AXITINIB (INLYTA). This represents 0.0% of all adverse event reports for AXITINIB.
7
Reports of Squamous cell carcinoma with AXITINIB
0.0%
of all AXITINIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Squamous cell carcinoma From AXITINIB?
Of the 7 reports, 3 (42.9%) required hospitalization.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which AXITINIB Alternatives Have Lower Squamous cell carcinoma Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE